ArticleJournal of cardiothoracic surgery2026
The association between postoperative nadir serum potassium and mortality within 28-day after aortic valve replacement.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to investigate the association between postoperative nadir serum potassium and 28-day mortality in patients undergoing surgical aortic valve replacement (SAVR) using the Medical Information Mart for Intensive Care (MIMIC-IV) database.
methodsA retrospective cohort study included 2,877 patients undergoing SAVR from MIMIC-IV. The independent variable was postoperative nadir serum potassium, and the primary outcome was 28-day all-cause mortality. Logistic regression models adjusted for sex, age, BMI, use of beta-blockers, antidiabetic drugs, diuretics, comorbidities (COPD, heart failure, peripheral vascular disease), and indexes of kidney (BUN, Creatinine). Restricted cubic spline (RCS) regression assessed the potential nonlinear relationship, and Kaplan-Meier survival curves compared mortality risk across different serum potassium levels.
resultsA U-shaped relationship was observed between postoperative nadir potassium and 28-day all-cause mortality. Higher nadir potassium levels were significantly associated with reduced mortality (odds ratio [OR] = 0.40, 95% confidence interval [CI]: 0.24-0.69, p < 0.001). The optimal threshold was 3.55 mmol/L; patients below this level had a markedly increased risk of death.
conclusionLower postoperative nadir serum potassium is independently associated with increased 28-day mortality in SAVR patients. Maintaining postoperative nadir serum potassium no lower than 3.5 mmol/L may be associated with reduced short-term mortality, although this threshold should not be interpreted as a target level to be constantly maintained. The nadir value represents only the lowest single measurement during ICU stay and does not reflect overall potassium homeostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.